Prognostic associations of the G8 geriatric screening tool in the EORTC Brain Tumor Group trials 1608 and 1709 in patients with newly diagnosed glioblastoma. (ASCO 2026) - Apr 21, 2026 - Abstract #e13777; P1, P3 | " Data from 99 patients aged 70 or older enrolled in the 1608 STEAM trial on the multikinase inhibitor zotiraciclib (NCT 03224104) (n = 23) or the 1709 MIRAGE trial on the proteasome inhibitor marizomib (NCT 03345095) (n = 76) were analyzed. The G8 score may be a powerful tool for prognostic assessment and for patient stratification in old and frail patients with glioblastoma. It may help to identify patients in need of early involvement of a palliative care team."
Clinical • Brain Cancer • Glioblastoma • Oncology • Solid Tumor
|
|
Michael Weller; Luc Boone; Patrick Roth; Matthias Preusser; Lissandra Dal Lago; Paolo Bossi; Warren Mason; Thierry Gorlia; Murielle Mauer; Emilie Le Rhun
|